Cargando…
Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons
Painful neuropathy is the major dose-limiting side effect of paclitaxel chemotherapy. Mitochondrial dysfunction and adenosine triphosphate (ATP) deficit have previously been shown in peripheral nerves of paclitaxel-treated rats, but the effects of paclitaxel in the dorsal root ganglia (DRGs) have no...
Autores principales: | Duggett, Natalie A., Griffiths, Lisa A., Flatters, Sarah J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515641/ https://www.ncbi.nlm.nih.gov/pubmed/28541258 http://dx.doi.org/10.1097/j.pain.0000000000000939 |
Ejemplares similares
-
Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy
por: Duggett, Natalie A., et al.
Publicado: (2016) -
Evoked and Ongoing Pain-Like Behaviours in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy
por: Griffiths, Lisa A., et al.
Publicado: (2018) -
Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy
por: Griffiths, Lisa A., et al.
Publicado: (2015) -
Characterization of a rat model of bortezomib‐induced painful neuropathy
por: Duggett, Natalie A, et al.
Publicado: (2017) -
Calcium Imaging of Parvalbumin Neurons in the Dorsal Root Ganglia
por: Walters, Marie C., et al.
Publicado: (2019)